Revealed: 3 Stocks for Potentially Massive Gains
Here is the latest financial fact sheet of Procter & Gamble Health. For more details, see the Procter & Gamble Health quarterly results and Procter & Gamble Health share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | 0.7 |
No. of shares | m | 16.60 |
% ch week | % | 0.9 |
% ch 1-mth | % | -5.0 |
% ch 12-mth | % | 43.3 |
52 week H/L | Rs | 7,500.0/3,750.0 |
No. of Mths Year Ending |
12 Dec-14 |
12 Dec-15 |
12 Dec-16 |
12 Dec-17 |
12 Dec-18 |
5-Yr Chart Click to enlarge
|
---|
PROCTER & GAMBLE HEALTH EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 919 | 1,004 | 1,060 | 1,358 | 3,549 | |
Low | Rs | 536 | 716 | 623 | 933 | 1,301 | |
Sales per share (Unadj.) | Rs | 522.6 | 566.0 | 597.9 | 420.6 | 511.4 | |
Earnings per share (Unadj.) | Rs | 26.0 | 32.3 | 45.7 | 36.8 | 61.3 | |
Diluted earnings per share | Rs | 26.0 | 32.3 | 45.7 | 36.8 | 61.3 | |
Cash flow per share (Unadj.) | Rs | 33.7 | 46.4 | 60.7 | 48.3 | 74.0 | |
Dividends per share (Unadj.) | Rs | 6.00 | 7.50 | 11.00 | 15.00 | 440.00 | |
Adj. dividends per share | Rs | 6.00 | 7.50 | 11.00 | 15.00 | 440.00 | |
Dividend yield (eoy) | % | 0.8 | 0.9 | 1.3 | 1.3 | 18.1 | |
Book value per share (Unadj.) | Rs | 333.9 | 356.4 | 388.8 | 441.7 | 927.8 | |
Adj. book value per share | Rs | 333.9 | 356.4 | 388.8 | 441.7 | 927.8 | |
Shares outstanding (eoy) | m | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 | |
Bonus/Rights/Conversions | - | - | - | - | - | ||
Price / Sales ratio | x | 1.4 | 1.5 | 1.4 | 2.7 | 4.7 | |
Avg P/E ratio | x | 27.9 | 26.7 | 18.4 | 31.1 | 39.6 | |
P/CF ratio (eoy) | x | 21.6 | 18.5 | 13.9 | 23.7 | 32.8 | |
Price / Book Value ratio | x | 2.2 | 2.4 | 2.2 | 2.6 | 2.6 | |
Dividend payout | % | 23.0 | 23.2 | 24.1 | 40.8 | 717.9 | |
Avg Mkt Cap | Rs m | 12,075 | 14,276 | 13,969 | 19,011 | 40,257 | |
No. of employees | `000 | 1.5 | 1.6 | 1.6 | 1.5 | 1.1 | |
Total wages/salary | Rs m | 1,136 | 1,234 | 1,542 | 1,099 | 1,313 | |
Avg. sales/employee | Rs Th | 5,726.0 | 6,045.7 | 6,270.1 | 4,521.6 | 7,486.7 | |
Avg. wages/employee | Rs Th | 749.6 | 794.0 | 974.3 | 711.7 | 1,157.6 | |
Avg. net profit/employee | Rs Th | 285.3 | 344.7 | 479.4 | 395.3 | 897.2 |
PROCTER & GAMBLE HEALTH INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 8,675 | 9,395 | 9,926 | 6,981 | 8,490 | |
Other income | Rs m | 203 | 233 | 244 | 241 | 244 | |
Total revenues | Rs m | 8,878 | 9,628 | 10,170 | 7,222 | 8,734 | |
Gross profit | Rs m | 589 | 834 | 1,106 | 770 | 1,482 | |
Depreciation | Rs m | 127 | 234 | 248 | 191 | 211 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit before tax | Rs m | 666 | 833 | 1,102 | 819 | 1,514 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 170 | 66 | |
Tax | Rs m | 233 | 298 | 343 | 379 | 563 | |
Profit after tax | Rs m | 432 | 536 | 759 | 610 | 1,017 | |
Gross profit margin | % | 6.8 | 8.9 | 11.1 | 11.0 | 17.5 | |
Effective tax rate | % | 35.1 | 35.7 | 31.1 | 46.2 | 37.1 | |
Net profit margin | % | 5.0 | 5.7 | 7.6 | 8.7 | 12.0 |
PROCTER & GAMBLE HEALTH BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 4,986 | 5,643 | 6,361 | 7,523 | 15,343 | |
Current liabilities | Rs m | 1,352 | 1,503 | 1,864 | 2,253 | 1,960 | |
Net working cap to sales | % | 41.9 | 44.1 | 45.3 | 75.5 | 157.6 | |
Current ratio | x | 3.7 | 3.8 | 3.4 | 3.3 | 7.8 | |
Inventory Days | Days | 75 | 64 | 60 | 82 | 49 | |
Debtors Days | Days | 44 | 47 | 39 | 64 | 28 | |
Net fixed assets | Rs m | 1,373 | 1,387 | 1,406 | 1,240 | 1,209 | |
Share capital | Rs m | 166 | 166 | 166 | 166 | 166 | |
"Free" reserves | Rs m | 5,374 | 5,844 | 6,472 | 7,167 | 15,235 | |
Net worth | Rs m | 5,543 | 5,916 | 6,455 | 7,333 | 15,401 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 7,082 | 7,784 | 8,792 | 9,912 | 17,595 | |
Interest coverage | x | NM | NM | NM | NM | NM | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.2 | 1.2 | 1.1 | 0.7 | 0.5 | |
Return on assets | % | 6.1 | 6.9 | 8.6 | 6.2 | 5.8 | |
Return on equity | % | 7.8 | 9.1 | 11.8 | 8.3 | 6.6 | |
Return on capital | % | 12.0 | 14.1 | 17.1 | 13.5 | 10.3 | |
Exports to sales | % | 7.8 | 8.5 | 8.8 | 0 | 0 | |
Imports to sales | % | 22.8 | 21.6 | 22.3 | 0 | 0 | |
Exports (fob) | Rs m | 677 | 802 | 869 | 0 | 0 | |
Imports (cif) | Rs m | 1,981 | 2,026 | 2,209 | 0 | 0 | |
Fx inflow | Rs m | 824 | 874 | 959 | 1,015 | 1,636 | |
Fx outflow | Rs m | 2,311 | 2,356 | 2,612 | 3,043 | 4,368 | |
Net fx | Rs m | -1,487 | -1,483 | -1,653 | -2,028 | -2,732 |
PROCTER & GAMBLE HEALTH CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 50 | 835 | 1,070 | 537 | -1,304 | |
From Investments | Rs m | 106 | -678 | -750 | -476 | 12,697 | |
From Financial Activity | Rs m | -166 | -119 | -150 | -220 | -301 | |
Net Cashflow | Rs m | -11 | 37 | 171 | -160 | 11,093 |
Share Holding
|
Company Information
|
CHM: S. N. Talwar | COMP SEC: Vikas R. Gupta | YEAR OF INC: 1967 | BSE CODE: 500126 | FV (Rs): 10 | DIV YIELD (%): 7.1 |
Read: PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: ALEMBIC PHARMA WOCKHARDT PIRAMAL ENTERPRISES AUROBINDO PHARMA VENUS REMEDIES
Compare PROCTER & GAMBLE HEALTH With: ALEMBIC PHARMA WOCKHARDT PIRAMAL ENTERPRISES AUROBINDO PHARMA VENUS REMEDIES
Compare PROCTER & GAMBLE HEALTH With: MYLAN (US) ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.
For the quarter ended June 2020, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 692 m (up 57.0% YoY). Sales on the other hand came in at Rs 6 bn (up 171.6% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.
For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.
Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
What should you do if the market falls? In this video, I'll tell you what I will do.
A favourable demand supply scenario makes a strong case for real estate prices.
Rahul Shah on whether Bharti Airtel will emerge as the next big thing in the Indian stock market
More